Quarterly report pursuant to Section 13 or 15(d)

Supplemental Condensed Consolidated Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details)

v3.24.3
Supplemental Condensed Consolidated Balance Sheet Information - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued consulting $ 78,447 $ 49,395
Accrued compensation 653,230 635,451
Accrued research and development 1,416,647 1,472,292
Accrued other 13,050 102,817
Total accrued expenses and other current liabilities $ 2,161,374 $ 2,259,955